(Q38434246)

3 September 2017

title

Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices (English)

1 reference

3 September 2017

1 reference

0 references

3

Noni E MacDonald

1 reference

SAGE Working Group on Vaccine Hesitancy

3 September 2017

series ordinal

5

object named as

SAGE Working Group on Vaccine Hesitancy

1 reference

3 September 2017

4

Robb Butler

1 reference

3 September 2017

Glen J Nowak

1

1 reference

3 September 2017

Bruce G Gellin

series ordinal

2

1 reference

3 September 2017

language of work or name

English

0 references

publication date

18 April 2015

1 reference

3 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

3 September 2017

volume

33

1 reference

3 September 2017

issue

34

1 reference

3 September 2017

page(s)

4204-4211

1 reference

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Mapping vaccine hesitancy--country-specific characteristics of a global phenomenon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Strategies for addressing vaccine hesitancy - A systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Vaccine hesitancy: Definition, scope and determinants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

A public health achievement under adversity: the eradication of poliomyelitis from Peru, 1991.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Social marketing as a strategy to increase immunization rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Promotional communications for influenza vaccination: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Changing health behaviors with social marketing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Addressing the vaccine confidence gap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Evaluating a County-Sponsored Social Marketing Campaign to Increase Mothers' Initiation of HPV Vaccine for their Pre-teen Daughters in a Primarily Rural Area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

The architecture of provider-parent vaccine discussions at health supervision visits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

HPV vaccine hesitancy: findings from a statewide survey of health care providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

The politics of HPV vaccination policy formation in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

HPV vaccine acceptability in Africa: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Barriers to and facilitators of child influenza vaccine - perspectives from parents, teens, marketing and healthcare professionals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Social marketing of water and sanitation products: a systematic review of peer-reviewed literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

An audience-channel-message-evaluation (ACME) framework for health communication campaigns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

'Get Your Life Back': process and impact evaluation of an asthma social marketing campaign targeting older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Theory and model use in social marketing health interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

The effectiveness of social marketing interventions for health improvement: what's the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Lessons for public health campaigns from analysing commercial food marketing success factors: a case study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Account planning: applying an advertising discipline to health communication and social marketing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

Parental acceptance of HPV vaccine in Peru: a decision framework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

The patient-consumer-advocate nexus: the marketing and dissemination of gardasil, the human papillomavirus vaccine, in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.039

10.1016/J.VACCINE.2015.04.039

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference